Get Ready for BOFAS 2024 Get Ready for BOFAS 2024 Download the App Now! 03 March 2024 This year we are all digital - download the BOFAS Conference App on the Play Store or the App Store. Read more
BOFAS 2024 Programme Now Live BOFAS 2024 Programme Now Live Registration Rates Increasing from Jan 2024 - Sign up now! 21 December 2023 Click here to see the BOFAS 2024 Programme! Read more
BOFAS 2024 Guest Speakers BOFAS 2024 Guest Speakers Click here to see who the BOFAS 2024 guest speakers are! 20 October 2023 Read more
20Apr2026 BOFAS Diabetic Foot Principles Course 20/04/2026 Read more BOFAS Diabetic Foot Principles Course 20th April 2026, Delta by Marriott Hotel, Milton Keynes £150.00 Read more
29Apr2026 BOFAS Trauma Course 29/04/2026 Read more BOFAS Trauma Course 29th April 2026, Bristol £150 Read more
15May2026 BOFAS Allied Health Professionals Course 15/05/2026 Read more BOFAS Allied Health Professionals Course 15th May 2026, Bournemouth Read more
2Jul2026 BOFAS Basics & Advanced Arthroscopy Skills Course 02/07/2026 Read more BOFAS Basics & Advanced Arthroscopy Skills Course 2nd-3rd July 2026, Solihull Read more
1Oct2026 BOFAS Principles Course 01/10/2026 Read more BOFAS Principles Course 1st-2nd October 2026, Glasgow £325.00 Read more
6May2026 Nordic Foot & Ankle Congress 06/05/2026 - 07/05/2026 Read more Nordic Foot & Ankle Congress BOFAS Members have been invited to the Nordic Foot & Ankle Congress May 6/7 2026 in Oslo. Read more
1Oct2026 EFAS 2026 - Augsburg, Germany 01/10/2026 - 03/04/2056 Read more EFAS 2026 - Augsburg, Germany October 1-3, 2026 Kongress am Park, Augsburg, Germany Read more
Togay Koç / 20 April 2024 / Categories: Abstracts, 2024, Poster Long-term follow up of TAR in patients with juvenile idiopathic arthritis J.G. Kimani, C. Loizou, R. Brown, B. Sharp, A. Kendal Background: Juvenile idiopathic arthritis (JIA) is a chronic immune-mediated arthropathy characterised by its earlyonset and multi-joint involvement. Ankle arthritis secondary to JIA is functionally debilitating. In those patients with end-stage disease, the surgical options include ankle arthroplasty or fusion. Total ankle replacement (TAR) has the perceived advantage of maintaining ankle-hindfoot movement in a patient group with widespread joint involvement. Methods: We performed a single centre study of all patients with JIA receiving a TAR since 2000. The primary outcome measure was revision surgery. Secondary outcome measures included radiographic evidence of failure and PROMS. Result: 26 TAR (12 Mobility and 14 STAR) were performed in 17 patients with JIA (mean age 40.4 years; range 21-63). There was radiographic evidence of failure in 50% of TAR. Typically TAR failed with total talar collapse. 31% of TAR were surgically revised to fusion in all but one case. The 10 and 15 year survival rates were 70% and 30%, respectively. Radiographic failure was associated with a raised MOXFQ score (median = 43) compared to patients with normal TAR radiographs (median = 33.5) and those that underwent revision (median = 35.5). Despite 77% of TAR for JIA remaining painful, 86% reported an improvement in pain post-TAR and 71% would recommend the operation to a friend/family member with the same condition. In a global assessment of joints, 48% rated it as “one of their better joints”. Conclusion: TAR in the context of JIA is associated with high rates of radiographic failure (including talar collapse), high revision rates and poor MOXFQ scores. However, patient satisfaction from this treatment remains high in the context of their global joint disease. Print 702 Tags: TAR Documents to download P3-Kimani-Jesse-Kimani-Jesse-Kimani(.pdf, 274.11 KB) - 1099 download(s)